We characterized a collection of IMI-like-producing Enterobacter spp. isolates (n = 112) in France. The main clone corresponded to IMI-1-producing sequence type 820 E. cloacae subspecies cloacae that was involved in an outbreak. Clinicians should be aware of potential antimicrobial resistance among these bacteria.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11138976PMC
http://dx.doi.org/10.3201/eid3006.231525DOI Listing

Publication Analysis

Top Keywords

imi-type carbapenemase-producing
4
carbapenemase-producing enterobacter
4
enterobacter cloacae
4
cloacae complex
4
complex france
4
france overseas
4
overseas regions
4
regions 2012-2022
4
2012-2022 characterized
4
characterized collection
4

Similar Publications

We characterized a collection of IMI-like-producing Enterobacter spp. isolates (n = 112) in France. The main clone corresponded to IMI-1-producing sequence type 820 E.

View Article and Find Full Text PDF

Nacubactam is a novel, broad-spectrum, β-lactamase inhibitor that is currently under development as combination therapy with meropenem. This study evaluated the efficacy of human-simulated epithelial lining fluid ELF) exposures of meropenem, nacubactam, and the combination of meropenem and nacubactam against class A serine carbapenemase-producing isolates in the neutropenic murine lung infection model. Twelve clinical meropenem-resistant , , and isolates, all harboring KPC or IMI-type β-lactamases, were utilized in the study.

View Article and Find Full Text PDF

Whole-genome sequencing was performed on 16 isolates of the carbapenemase-producing complex to determine the flanking regions of -type genes. Phylogenetic analysis of multilocus sequence typing (MLST) targets separated the isolates into 4 clusters. The -type genes were all found on Xer-dependent integrative mobile elements (IMEX).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!